Barclays raised the firm’s price target on Insulet (PODD) to $300 from $266 and keeps an Equal Weight rating on the shares. The firm updated the company’s model to reflect management’s commentary and updated 2025 outlook.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PODD: